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ess: calogero.cipolla@tSummary Over the last few years, there has been an enormous increase in the use
of needle core biopsy (CB) for the histopathological characterisation of suspect
lesions of the breast. The aim of this study was to verify the diagnostic reliability of
CB by comparing the histological results obtained with the use of this technique with
those obtained from the whole of the surgically resected specimen. We studied 198
out of 426 patients with clinically and/or radiologically suspect breast lesions. We
found correspondence between the histological examination of the whole of the
excised specimen and that of the CB in 94.9% of the cases of infiltrating carcinoma
and in 71.4% of those involving ductal carcinomas in situ. The predictive value of CB
was 98.9%, sensitivity was 96.1% and specificity 93.3%. These results confirmed that
CB is an extremely reliable diagnostic tool in the definition of breast lesions.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Over the last few years, there has been a
considerable increase in the use of needle core
biopsy (CB) for the histopathological characterisa-
tion of suspect breast lesions and it has now
become a first-choice diagnostic procedure repla-
cing traditional excisional biopsy.1,2 It follows,
therefore, that as the use of CB becomes moreElsevier Ltd. All rights reserv
6554520;
in.it (C. Cipolla).and more frequent, there will be a concomitant
reduction in the number of diagnostic surgical
biopsies and intraoperative histological examina-
tions.1
Several published reports have demonstrated
that in a high percentage of cases the histological
results of CB concur with those obtained from the
examination of the whole of the excised speci-
men.3–9 Furthermore, CB provides an extremely
high level of diagnostic reliability, not only with
regard to cases of infiltrating carcinoma, but also to
those involving atypical hyperplasia, lobular carci-
nomas in situ,10–16 ductal carcinomas in situed.
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benign breast diseases.18,19
Although CB has not completely replaced tradi-
tional excisional biopsy, it is considered to be a
valid diagnostic procedure, since it is not only
efficient but also well tolerated and not particu-
larly invasive, making it possible for the surgeon to
provide the patient with a great deal of information
regarding her disease and to plan a more specific
therapeutic approach.
The aim of this study is to verify the reliability of
CB for the diagnosis of breast lesions by comparing
the histological results obtained using this proce-
dure with those resulting from the examination of
the whole of the excised specimen, in a consecu-
tive series of suspect breast lesions, in order to
evaluate the possible routine use of CB instead of
surgical biopsy in the diagnostic work-up of such
lesions.Materials and methods
Four hundred and twenty-six consecutive patients
with clinically and/or radiologically suspect breast
lesions underwent CB in our Institute from Septem-
ber 1999 to February 2004. In 302 cases (70.9%),
there was only a radiological suspicion of the
lesions since they were not clinically palpable.
These lesions, with or without microcalcifications,
presented a Breast Imaging Reporting and Data
System (BI-RADS) risk of 3–5. In 124 cases (29.1%),
the lesions were not only identified by X-ray but
were also clinically palpable. In all cases the lesions
were evaluated both by a breast X-ray specialist
and by a surgeon.
Surgical excision was performed in 198 cases
(46.5%) and the histological CB result was com-
pared with that obtained from the whole of the
excised specimen. Ninety-two of these lesions
(46.5%) were clinically palpable, while 106
(53.6%) were not (Table 1).Table 1 Description of the 426 lesions investigated usin
Clinically and/or radiologically suspect lesions
Radiologically suspect lesions (clinically non-palpable):
BI-RADS 3
BI-RADS 4
BI-RADS 5
TotalSix months and 1 year after the CB, the
remaining 228 patients (53.5%) underwent clinical
and X-ray examinations of their lesions, and the
benign status of the lesions obtained from the
histological results of the CB was found to be
compatible with the clinical and mammographic
diagnosis of probable benignity (BI-RADS 3).
CB was performed with 14-gauge needles. Two to
five stereotactically guided samples (with an
average of three) were taken from each of the
non-palpable lesions, while in the 92 clinically
palpable lesions the CB was performed manually
with ultrasound guidance.
From a histological point of view, the lesions were
classified as infiltrating carcinomas (IC), DCIS,
hyperplasia with atypical cells (AH) and benign
lesions (BL). The results of the histological exam-
inations of the whole of the excised specimens were
then compared with those obtained from the CB.
In all the cases, the operations were performed
by expert breast surgeons and decisions regarding
the type and extent of the procedure were based
both on the histological evaluation of the CB and on
the clinical and/or mammographic characteristics
of the lesions. Where the CB examination produced
a clinically and/or mammographically confirmed
diagnosis of IC, quadrantectomy or full mastectomy
was performed, associated with complete axillary
dissection or with biopsy of the sentinel lymph
node. In all the other cases, only the lesion was
surgically removed.
Where the lesions were clinically non-palpable,
they were localised before surgery by the stereo-
tactically guided insertion of a metal thread.
Correct removal of the lesion was confirmed by an
X-ray of the excised specimen.Results
In our Institute, from September 1999 to February
2004, CBs were performed on 426 clinically and/org core biopsy.
Surgical removal Follow-up Total
92 32 124
18 196 214
45 — 45
43 — 43
198 228 426
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(53.5%) histological examination by CB produced
a benign result, confirmed by the clinical and
mammographic features of the lesion. In these
patients, clinical and X-ray examinations were
repeated 6 months and 1 year after CB. During
these follow-up examinations, in no cases were any
changes observed that might require a re-evalua-
tion by a second CB or the surgical removal of the
nodule for histological examination of the operated
specimen.
In 198 cases (46.5%) it was possible to compare
the CB result with that obtained from the excisional
biopsy. In 106 cases (53.5%) the mammary lesions
were non-palpable, while 92 cases (46.5%) involved
clinically palpable lesions.
The histological examination of the 198 lesions
performed on the whole of the excised specimens
diagnosed 176 (88.9%) ICs, 7 (3.5%) DCIS, 10 (5.1%)
AHs and 5 (2.4%) BLs (Table 2).
CB examination of the 92 palpable mammary
lesions resulted in 90 (97.8%) ICs, one (1.1%) DCIS
and one (1.1%) AH. In all these cases (100%), these
results were confirmed by the histological exam-
ination of the whole lesion after surgical removal.
Histological examination of the whole of the
excised specimens from the 106 non-palpable
lesions resulted in 86 (81.1%) cases of IC, six
(5.6%) of DCIS, nine (8.5%) of AH and five (4.7%)
of BL. Of the 86 cases of IC, 77 (89.5%)
were confirmed by CB, while in five cases (5.8%)
CB produced a diagnosis of AH, in three cases
(3.5%) of DCIS and in one case (1.2%) of BL.
Histological examination of the CB in the six DCIS
cases resulted in four cases (66.7%) of DCIS, one
case (16.6%) of AH and one case (16.6%) of IC. In all
nine cases of AH (100%) there was agreement
between the histological examination of the CB and
of the whole of the surgical specimen, and one
(20%) of the five BL cases was confirmed by the CB
examination. This particular case involved an
adenomyoepithelioma, which is a fairly uncommon
breast tumour.Table 2 Histological results of 169 excised lesions.
Clinically non-palpable lesions
No. %
Infiltrating carcinoma 86 81.1
Ductal carcinoma in situ 6 5.6
Atypical hyperplasia 9 8.5
Benign lesions 5 4.7
Total 106 100In conclusion, therefore, correspondence be-
tween the histological examination performed on
the CB sample and that obtained from the excised
specimen was found in all (100%) of the palpable
lesions and in 94 (88.6%) of the non-palpable
lesions. Of the 176 cases of IC identified by the
histological examination of the excised specimen,
CB confirmed the diagnosis in 167 (94.9%), while
five (71.4%) of the seven DCIS were also confirmed
by CB. This indicated a positive predictive value
(PPV) for the CB technique of 98.9%, sensitivity of
96.1% and specificity of 93.3%. If the 228 patients
with lesions undergoing X-ray follow-up after a CB
histological result of benignity are included as true
negatives, the specificity of the method is even
higher and reaches 99.1% (Table 3).Discussion
Over the last few years, there has been such an
increase in the use of needle CB for the histological
characterisation of suspect breast lesions that,
where possible, it is now always advised as the
first-choice procedure for the histological definition
of breast lesions in place of traditional excisional
biopsy.1,2
Although without doubt one of the great advan-
tages of the method is that it can be used for
radiologically suspect preclinical lesions, its use
can also be extended to the study of clinically
palpable lesions in order to confirm a clinical and
X-ray diagnosis of fairly probable or even certain
carcinoma. In this way, at the moment of surgery,
the therapeutic approach has already been de-
fined, making it possible to avoid intraoperative
biopsy. Furthermore, in cases in which preoperative
chemotherapy is indicated, CB provides not only
the histological typing of the tumour, but also a
definition of the prognostic factors without the use
of surgical biopsy.
CB makes it possible to avoid the surgical
removal of those lesions for which a diagnosis ofClinically palpable lesions Total
No. % No. %
90 97.8 176 88.9
1 1.1 7 3.5
1 1.1 10 5.1
5 2.5
92 100 198 100
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Table 3 Histological results of core biopsy compared with those of excisional biopsy.
Core biopsy Surgical biopsy
Infiltrating
carcinoma
Ductal carcinoma
in situ
Atypical
hyperplasia
Benign
lesion
Total
Infiltrating carcinoma 167 1 1 169
Ductal carcinoma in situ 3 5 8
Atypical hyperplasia 5 1 10 16
Benign lesions 1 4 5
Total 176 7 10 5 198
Positive predictive value 98.9%; sensibility 96.1%; specificity 93.3%.
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radiological features. In our experience, in 228
patients (53.5%) in whom the histological result of
the CB diagnosed benignity and in whom the lesion
did not demonstrate any features that might be
considered clinically or radiologically suspect,
surgical removal was not performed, resulting in a
reduction in cost and a high level of patient
compliance. In all the cases concerned, ultrasound
and radiographic examinations performed 6 months
and 1 year after CB showed no modifications of the
lesions. It goes without saying, therefore, that CB
made it possible to avoid the surgical removal of
such lesions.
Although our results demonstrate that most of
the CBs performed by us involved BL that did not
require surgery, the majority of the lesions that
were surgically removed after CB proved to be
malignant. Of the 198 patients undergoing surgery
after CB, 176, in fact, had ICs and seven had DCIS,
making a total of 183 malignant neoplasias, or
92.4% of all the patients operated on. Of the non-
palpable lesions removed, 86 were ICs and six were
DCIS, totalling 92 malignancies out of 106 surgically
removed lesions (86.7%). Of the palpable lesions
removed, 90 were ICs and one was a DCIS, out of a
total of 92 lesions removed (98.9%).
In only 15 cases (7.6%) did the lesions that were
removed prove to be benign, but 10 of these
(66.7%) involved lesions demonstrating atypical
histological features, while one was an adenomyoe-
pithelioma diagnosed by CB as an IC. In four cases
(2%), the lesions removed after CB proved to be
benign, but all were non-palpable lesions removed
using the stereotactically guided advanced breast
biopsy instrument (ABBI) method and diagnosed
histologically as fibroadenomas of the breast.
The low rate of surgical removal for BL and, on
the other hand, the high incidence of malignant
neoplasias, are in our experience most likely due to
the careful, accurate selection methods used forthe indications for CB. This is the result not only of
several years of study and work involving preclini-
cal breast lesions, but also of extremely fruitful
multidisciplinary cooperation in our Institute be-
tween radiologists, surgeons and pathologists. This
fact concurs with recently published reports on the
same subject by several other authors1–5 and,
furthermore, emphasises the fact that, in the last
few years, experience with the use of CB has led to
an increase in the diagnosis of ICs using this
procedure, compared with the results published a
few years ago,3,6,8,10 when the rates of diagnosis of
breast carcinomas using CB ranged from 8% to 42%.
Another fact that emerged from our own study is
the high correspondence between the histological
examination of the CB and the traditional exci-
sional biopsy, which was 93.9%. In fact, in the 92
palpable lesions, there was 100% correspondence
between CB results and those of the traditional
surgical biopsy, while in the 106 non-palpable
lesions, in only seven out of 92 cases (6.6%) did
the CB examination give a false-negative result,
although six of these cases involved an AH. In only
one case (0.94%) did the histological examination of
CB give a false-positive result; the histological
examination of the surgical specimen diagnosed
this case as an adenomyoepithelioma, which is in
fact a fairly breast tumour.
In our opinion, CB histologic underestimation
concerns mostly non-palpable lesions and does not
present any particular problems. Histological ex-
amination of the CB produced a completely benign
result in only one case out of the 86 non-palpable
ICs; in five cases it resulted in an AH and in three
cases a DCIS, all lesions requiring surgical removal
in order to perform a complete histological
evaluation. In any case, however, it should be
borne in mind that before any decision is made, the
CB histologic result should be compared with those
of the clinical and/or radiological examinations,
and surgical removal should be performed if the
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the CB produced a benign result.
The positive predictive value of CB in the
definition of the histological nature of the lesion
(98.9%) and the sensitivity of the method (96.1%)
both proved to be extremely high. One hundred and
eighty-three of the 198 surgically removed lesions
were in fact malignant. CB specificity was also high
at 99.1%, since if all 228 patients with a benign
histological result from CB in whom surgery was not
performed, but who were subjected to X-ray
follow-up are considered true negatives, the
number of BL removed was extremely low. Further-
more, in ten patients (66.7%) in whom BL were
removed, the lesions proved to be cell atypia,
which should in any case be removed.Conclusions
In conclusion, our results concur with those of
previously published reports, i.e. that CB is an
extremely efficient tool for the histological defini-
tion of breast lesions. Since the positive predictive
value of the technique is very high, a positive
histological result for malignant neoplasia with the
use of CB should be taken fairly seriously with
regard to therapeutic programming and informa-
tion given to the patient, as confirmed by several
other authors,15 and may make it possible to avoid
intraoperative biopsy. Only if there is discordance
between the histological results of the CB and the
X-ray result should surgical biopsy be considered
imperative. In any case in which the lesion is
radiologically or clinically suspect, however, even
when the CB leads to a benign histological result, it
is extremely important to make a careful evalua-
tion of the correspondence between the mammo-
graphic result, the clinical features of the lesion
and the histological findings, and to proceed if
necessary to surgical biopsy.References
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